Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.45 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.42 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3868745 | 0.95 | PTPN11 (0.51) | LTA4HPDK2PTPN11PTPN1GPBAR1 | |
| SCHEMBL3868820 | 0.95 | PTPN11 (0.51) | LTA4HPDK2PTPN11PTPN1GPBAR1 | |
| SCHEMBL3870558 | 0.87 | L3MBTL1 (0.47) | LTA4HPDK2NPC1ALDH1A1MAPT | |
| SCHEMBL3876767 | 0.78 | CYP1A2 (0.45) | PDK2KMT2AMEN1NPC1ALDH1A1 | |
| SCHEMBL18015983 | 0.73 | MAPT (0.69) | PDK2PTPN11KMT2AMEN1NPC1 | |
| SCHEMBL3879642 | 0.73 | PDK2 (0.42) | PDK2KMT2AMEN1NPC1ALDH1A1 | |
| SCHEMBL3879614 | 0.73 | GPR3 (0.52) | ALDH1A1CYP3A4 | |
| SCHEMBL14288507 | 0.72 | MAPT (0.72) | PTPN11KMT2AMEN1NPC1ALDH1A1 | |
| SCHEMBL5316394 | 0.72 | HCAR2 (0.40) | PDK2KMT2AMEN1ALDH1A1 | |
| SCHEMBL27670055 | 0.71 | PTPN1 (0.58) | LTA4HPDK2PTPN11KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2657315-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2020-12-16 | — | — | EP | disclosed |
| CN-103562342-B | Organic light emitting device and method of manufacturing the same | 株式会社LG化学 | 2017-02-15 | — | — | CN | disclosed |
| US-9349964-B2 | Organic light emitting diode and manufacturing method thereof | LG CHEM, LTD. (KR) | 2016-05-24 | — | — | US | disclosed |
| EP-2657315-A2 | ORGANIC LIGHT-EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | LG Chem, Ltd. (KR) | 2013-10-30 | — | — | EP | disclosed |
| US-20120193612-A1 | ORGANIC LIGHT EMITTING DIODE AND MANUFACTURING METHOD THEREOF | LG CHEM, LTD. (KR) | 2012-08-02 | — | — | US | disclosed |
| US-7482490-B2 | Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound | TOSOH CORPORATION (JP) | 2009-01-27 | — | — | US | disclosed |
| US-20080194878-A1 | Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound | TOSOH CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-7189877-B2 | Arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | TOSCH CORPORATION (JP) | 2007-03-13 | — | — | US | disclosed |
| EP-1752440-A1 | AMINE COMPOUND HAVING FLUORENE GROUP AS FRAMEWORK, PROCESS FOR PRODUCING THE AMINE COMPOUND, AND USE OF THE AMINE COMPOUND | Tosoh Corporation (JP) | 2007-02-14 | — | — | EP | disclosed |
| EP-1400578-B1 | Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives | TOSOH CORP (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-20040110958-A1 | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | TOSOH CORPORATION | 2004-06-10 | — | — | US | disclosed |
| EP-1400578-A1 | Electrolumisescent 9,9-bis(4-amino)-1,1'-biphenyl)fluorene derivatives | Tosoh Corporation (JP) | 2004-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110958-A1 | Novel arylamine derivatives having fluorene skeleton, synthetic intermediates thereof, processes of producing those, and organic electrolumivescene devices | AHR, NAT1, AR | LTA4H 1441/4885PDK2 2093/4885PTPN11 4529/4885 |
| US-20080194878-A1 | Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound | TAAR1, SLC18A1, ADRB2 | LTA4H 1727/4885PDK2 3867/4885PTPN11 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.